14 insiders reported 106 Form 4 transactions for Tarsus Pharmaceuticals, Inc. (TARS) over the past 18 months (most recent 2026-06-22). Recent activity: Azamian Bobak R. (President/CEO and Board Chair) Sell 5,418 shares, Azamian Bobak R. (President/CEO and Board Chair) Sell 4,582 shares, LINK WILLIAM J PHD (Director) Sell 10,572 shares, Farrow Jeffrey S (See Remarks) Buy 27,881 shares, Goodrich Katherine (Director) Sell 2,954 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Azamian Bobak R. | President/CEO and Board Chair | Sell | 5,418 | $334,887 |
| 2026-06-22 | Azamian Bobak R. | President/CEO and Board Chair | Sell | 4,582 | $280,602 |
| 2026-06-17 | LINK WILLIAM J PHD | Director | Sell | 10,572 | $655,147 |
| 2026-06-17 | Farrow Jeffrey S | See Remarks | Buy | 27,881 | $0 |
| 2026-06-17 | Goodrich Katherine | Director | Sell | 2,954 | $183,384 |
| 2026-06-17 | LINK WILLIAM J PHD | Director | Sell | 1,928 | $121,348 |
| 2026-06-17 | Farrow Jeffrey S | See Remarks | Sell | 14,396 | $877,436 |
| 2026-06-16 | Goodrich Katherine | Director | Buy | 2,954 | $0 |
| 2026-06-16 | LINK WILLIAM J PHD | Director | Buy | 2,954 | $0 |
| 2026-06-16 | CHAUDHURI BHASKAR | Director | Buy | 2,954 | $0 |
| 2026-06-16 | Morrison Scott W | Director | Buy | 2,954 | $0 |
| 2026-06-16 | Goldberg Andrew D. | Director | Buy | 2,954 | $0 |
| 2026-06-16 | YARNO WENDY L | Director | Buy | 2,954 | $0 |
| 2026-04-28 | PYOTT DAVID E I | Director | Buy | 1,383 | $0 |
| 2026-03-24 | Neervannan Seshadri | Chief Operating Officer | Sell | 2,989 | $199,516 |
| 2026-03-19 | Neervannan Seshadri | Chief Operating Officer | Sell | 3,125 | $216,938 |
| 2026-03-19 | Neervannan Seshadri | Chief Operating Officer | Sell | 3,610 | $248,043 |
| 2026-03-19 | Neervannan Seshadri | Chief Operating Officer | Sell | 4,589 | $307,463 |
| 2026-03-19 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 375 | $26,032 |
| 2026-03-19 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 379 | $26,041 |
| 2026-03-19 | Mottiwala Aziz | Chief Commercial Officer | Sell | 4,286 | $297,534 |
| 2026-03-19 | Wahl Bryan | General Counsel | Sell | 4,084 | $283,511 |
| 2026-03-19 | Wahl Bryan | General Counsel | Sell | 4,125 | $283,429 |
| 2026-03-19 | Wahl Bryan | General Counsel | Sell | 4,231 | $283,477 |
| 2026-03-19 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 390 | $26,130 |
Source: SEC Form 4 filings · as of 2026-06-22